Wire
Generate Biomedicines Shares Fall Following Q2 Financial Results
Generate Biomedicines (GENB) shares fell 4.6% in Thursday trading after the company posted a wider-than-expected Q2 net loss and lower revenue.The company reported Q2 net loss of $0.52 per diluted share, narrowing from a loss of $1.94 a year earlier.Four analysts surveyed by FactSet expected a loss of $0.50.Collaboration revenue for the quarter ended June 30 was $6.3 million, down from $10.1 million a year ago.Three analysts expected $5.5 million.Price: $13.83, Change: $-0.66, Percent Change: -4.55%
$GENB
